Yellow fever medical therapy

Jump to navigation Jump to search

Yellow fever Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Yellow Fever from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Future or Investigational Therapies

Treatment

Case #1

Yellow fever medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Yellow fever medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Yellow fever medical therapy

CDC on Yellow fever medical therapy

Yellow fever medical therapy in the news

Blogs on Yellow fever medical therapy

Directions to Hospitals Treating Yellow fever

Risk calculators and risk factors for Yellow fever medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]

Overview

There is no antivirals approved for the treatment of for yellow fever, therefore vaccination is important. Treatment is symptomatic and supportive only. Fluid replacement, managing hypotension and transfusion of blood derivates is generally needed only in severe cases. In cases that result in acute renal failure, dialysis may be necessary.

Medical Therapy

  • No specific antiviral treatment has been found to benefit patients with yellow fever.
  • Whenever possible, yellow fever patients should be hospitalized for supportive care and close observation.[1]
  • Treatment is symptomatic. Rest, fluids, and use of pain relievers and medication to reduce fever.
  • Care should be taken to avoid certain medications, such as aspirin or other nonsteroidal anti-inflammatory drugs, such as ibuprofen or naproxen, which may increase the risk of bleeding.
  • H2 receptor antagonists, such as ranitidine or famotidine, may be used to prevent or diminish the risk of gastric bleeding.
  • Yellow fever patients should be protected from further mosquito exposure (staying indoors and/or under a mosquito net) during the first few days of illness.
  • This way, yellow fever virus in their bloodstream will be unavailable to other uninfected mosquitoes, thus breaking the transmission cycle and reducing risk to the persons around them.

Antimicrobial Regimen

  • Preferred regimen: No specific treatment is available for yellow fever. In the toxic phase, supportive treatment includes therapies for treating dehydration and fever. Ribavirin has failed in several studies in the monkey model.
  • Note: An international seminar held by WHO in 1984 recommended maintenance of nutrition, prevention of hypoglycemia, maintenance of the blood pressure with fluids and vasoactive drugs, prevention of bleeding with fresh-frozen plasma, dialysis if renal failure, correction of metabolic acidosis, administration of cimetidine IV to avoid gastric bleeding and oxygen if needed.

References

  1. "CDC Yellow Fever - Symptoms and Treatment".
  2. "District guidelines for yellow fever surveillance" (PDF).
  3. name="pmid3547569">Monath TP (1987). "Yellow fever: a medically neglected disease. Report on a seminar". Rev Infect Dis. 9 (1): 165–75. PMID 3547569.